31st Annual Symposium on Nonhuman Primate Models for AIDS

第31届非人类灵长类艾滋病模型年度研讨会

基本信息

  • 批准号:
    8603581
  • 负责人:
  • 金额:
    $ 7.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This grant application is to obtain funds to partially support planning, organizing, publicizing and hosting the 31st Annual Symposium on Nonhuman Primate Models for AIDS. This symposium is a critical scientific forum that facilitates the dissemination and exchange of new research findings, ideas and directions, and encourages increased collaboration among investigators engaged in HIV/AIDS research using nonhuman primates (NHPs). The meeting, the only one of its kind in the world, convenes an international group of scientists whose research focuses on the study of natural and experimental immunodeficiency virus infections in NHP models as well as on the development of vaccines and alternate infection-prevention strategies and novel therapeutic options. The Yerkes National Primate Research Center will host the 2013 Symposium November 3-6, 2013, at the JW Marriot Atlanta Buckhead Hotel. Drs. Rama Amara and Stuart Zola will serve as Scientific Co-Chairs, and members of the Scientific Program Committee and the Organizing Committee will support them. The symposium program will comprise four half-day scientific sessions including "Latency and Reservoirs," "Natural hosts/New models," "Pathogenesis/Early events" and "Vaccines/Immunology," and two quarter-day scientific sessions, "Virus host interactions" and "Therapy/Microbicides." This year, we are offering innovative additions to the program to leverage our extensive local scientific expertise. We will host three consecutive 60-minute "Meet the Expert" breakout sessions ("Dendritic cell analyses in macaques," "Nonhuman primate genomics" and "Comparing immunogenicity in macaques and humans"), and we will implement "Conclusions and Takeaways" summaries by the session chairs at the conclusion of each scientific session. The symposium will also offer an educational outreach training session for local science teachers. The Symposium will begin with the breakout sessions. Following these will be the welcome reception and keynote speaker presentation. The next two and a half days will feature the scientific sessions as well as a poster reception and banquet. The 16-member Scientific Program Committee will review abstracts and assign oral and poster presentations for each of the scientific sessions. The committee will also award fellowships to the most meritorious abstracts from postdoctoral fellows and graduate students. In addition to any R13 grant support, registration fees and corporate sponsorship will help defray costs and fund the symposium. We are confident the knowledge gained from this symposium will shed light on how HIV and SIV cause disease and will bring us steps closer to developing an effective AIDS vaccine as well as novel therapies to control/cure HIV infection.
描述(由申请人提供):此赠款申请是为了获得资金,以部分支持规划,组织,宣传和主办第31届非人类灵长类动物艾滋病模型年度研讨会。本次研讨会是一个重要的科学论坛,促进传播和交流新的研究成果,想法和方向,并鼓励从事艾滋病毒/艾滋病研究使用非人灵长类动物(NHP)的调查人员之间加强合作。该会议是世界上唯一的此类会议,召集了一个国际科学家小组,其研究重点是研究NHP模型中的自然和实验免疫缺陷病毒感染以及疫苗和替代感染预防策略和新治疗方案的开发。耶基斯国家灵长类动物研究中心将于2013年11月3日至6日在亚特兰大巴克黑德JW万豪酒店举办2013年研讨会。拉马阿马拉和斯图尔特左拉博士将担任科学联合主席,科学计划委员会和组织委员会的成员将支持他们。研讨会计划将包括四个半天的科学会议,包括“潜伏期和水库”,“自然宿主/新模型”,“发病机制/早期事件”和“疫苗/免疫学”,以及两个四分之一天的科学会议,“病毒宿主相互作用”和“治疗/杀微生物剂”。“今年,我们将为该计划提供创新性的补充,以利用我们广泛的本地科学专业知识。我们将连续举办三次60分钟的“会见专家”分组会议(“猕猴中的树突状细胞分析”,“非人灵长类动物基因组学”和“比较猕猴和人类的免疫原性”),我们将在每次科学会议结束时由会议主席进行“结论和要点”总结。研讨会还将为当地科学教师提供教育推广培训课程。专题讨论会开始时将举行分组会议。随后将举行欢迎招待会和主旨演讲。接下来的两天半将举行科学会议以及海报招待会和宴会。由16名成员组成的科学计划委员会将审查摘要,并为每次科学会议分配口头和海报演示。委员会还将向博士后研究员和研究生中最有价值的摘要颁发奖学金。除了任何R13赠款支持,注册费和企业赞助将有助于支付费用和资助研讨会。我们相信,从这次研讨会上获得的知识将揭示艾滋病毒和SIV如何引起疾病,并将使我们更接近开发有效的艾滋病疫苗以及控制/治愈艾滋病毒感染的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rama Rao Amara其他文献

Rama Rao Amara的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rama Rao Amara', 18)}}的其他基金

B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
预防和根除 SIV/SHIV 感染的 B 和 T 细胞生物学
  • 批准号:
    10462362
  • 财政年份:
    2022
  • 资助金额:
    $ 7.2万
  • 项目类别:
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
预防和根除 SIV/SHIV 感染的 B 和 T 细胞生物学
  • 批准号:
    10618319
  • 财政年份:
    2022
  • 资助金额:
    $ 7.2万
  • 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 3
HCV 保护性免疫与合理疫苗设计的相关性:项目 3
  • 批准号:
    10393619
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 3
HCV 保护性免疫与合理疫苗设计的相关性:项目 3
  • 批准号:
    10205769
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
Correlates of protective immunity to HCV and rational vaccine design: Project 3
HCV 保护性免疫与合理疫苗设计的相关性:项目 3
  • 批准号:
    10608113
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
MVA based SARS-CoV-2 vaccines
基于 MVA 的 SARS-CoV-2 疫苗
  • 批准号:
    10221340
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
Combined cytokine therapy for sustained HIV remission
联合细胞因子疗法可持续缓解艾滋病毒
  • 批准号:
    10348184
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
Combined cytokine therapy for sustained HIV remission
联合细胞因子疗法可持续缓解艾滋病毒
  • 批准号:
    10573329
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
Targeting PD-1 Pathway for Functional Cure of AIDS
靶向 PD-1 通路实现艾滋病功能性治愈
  • 批准号:
    10349439
  • 财政年份:
    2019
  • 资助金额:
    $ 7.2万
  • 项目类别:
MVA Prime/Novel Trimeric Cyclically Permuted Envelope Protein Boost Vaccines for HIV
MVA Prime/新型三聚体循环排列包膜蛋白增强 HIV 疫苗
  • 批准号:
    10449340
  • 财政年份:
    2019
  • 资助金额:
    $ 7.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了